162 related articles for article (PubMed ID: 25527982)
1. LC-UV/MS methods for the analysis of prochelator-boronyl salicylaldehyde isonicotinoyl hydrazone (BSIH) and its active chelator salicylaldehyde isonicotinoyl hydrazone (SIH).
Bureš J; Jansová H; Stariat J; Filipský T; Mladěnka P; Šimůnek T; Kučera R; Klimeš J; Wang Q; Franz KJ; Kovaříková P
J Pharm Biomed Anal; 2015 Feb; 105():55-63. PubMed ID: 25527982
[TBL] [Abstract][Full Text] [Related]
2. Characterization of cytoprotective and toxic properties of iron chelator SIH, prochelator BSIH and their degradation products.
Jansová H; Bureš J; Macháček M; Hašková P; Jirkovská A; Roh J; Wang Q; Franz KJ; Kovaříková P; Šimůnek T
Toxicology; 2016 Mar; 350-352():15-24. PubMed ID: 27046792
[TBL] [Abstract][Full Text] [Related]
3. Comparison of various iron chelators and prochelators as protective agents against cardiomyocyte oxidative injury.
Jansová H; Macháček M; Wang Q; Hašková P; Jirkovská A; Potůčková E; Kielar F; Franz KJ; Simůnek T
Free Radic Biol Med; 2014 Sep; 74():210-21. PubMed ID: 24992833
[TBL] [Abstract][Full Text] [Related]
4. Iron prochelator BSIH protects retinal pigment epithelial cells against cell death induced by hydrogen peroxide.
Charkoudian LK; Dentchev T; Lukinova N; Wolkow N; Dunaief JL; Franz KJ
J Inorg Biochem; 2008 Dec; 102(12):2130-5. PubMed ID: 18835041
[TBL] [Abstract][Full Text] [Related]
5. Investigation of the stability of aromatic hydrazones in plasma and related biological material.
Kovaríková P; Mrkvicková Z; Klimes J
J Pharm Biomed Anal; 2008 Jun; 47(2):360-70. PubMed ID: 18294799
[TBL] [Abstract][Full Text] [Related]
6. A pro-chelator triggered by hydrogen peroxide inhibits iron-promoted hydroxyl radical formation.
Charkoudian LK; Pham DM; Franz KJ
J Am Chem Soc; 2006 Sep; 128(38):12424-5. PubMed ID: 16984186
[TBL] [Abstract][Full Text] [Related]
7. Development of high-performance liquid chromatographic determination of salicylaldehyde isonicotinoyl hydrazone in rabbit plasma and application of this method to an in vivo study.
Kovaríková P; Klimes J; Stĕrba M; Popelová O; Mokrý M; Gersl V; Ponka P
J Sep Sci; 2005 Aug; 28(12):1300-6. PubMed ID: 16138682
[TBL] [Abstract][Full Text] [Related]
8. Modifying aroylhydrazone prochelators for hydrolytic stability and improved cytoprotection against oxidative stress.
Wang Q; Franz KJ
Bioorg Med Chem; 2018 Dec; 26(22):5962-5972. PubMed ID: 30429096
[TBL] [Abstract][Full Text] [Related]
9. The hydrolytic susceptibility of prochelator BSIH in aqueous solutions.
Wang Q; Franz KJ
Bioorg Med Chem Lett; 2017 Sep; 27(17):4165-4170. PubMed ID: 28734582
[TBL] [Abstract][Full Text] [Related]
10. Prooxidant and antioxidant properties of salicylaldehyde isonicotinoyl hydrazone iron chelators in HepG2 cells.
Caro AA; Commissariat A; Dunn C; Kim H; García SL; Smith A; Strang H; Stuppy J; Desrochers LP; Goodwin TE
Biochim Biophys Acta; 2015 Nov; 1850(11):2256-64. PubMed ID: 26275495
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and initial in vitro evaluations of novel antioxidant aroylhydrazone iron chelators with increased stability against plasma hydrolysis.
Hruskova K; Kovarikova P; Bendova P; Haskova P; Mackova E; Stariat J; Vavrova A; Vavrova K; Simunek T
Chem Res Toxicol; 2011 Mar; 24(3):290-302. PubMed ID: 21214215
[TBL] [Abstract][Full Text] [Related]
12. The interaction of pyridoxal isonicotinoyl hydrazone (PIH) and salicylaldehyde isonicotinoyl hydrazone (SIH) with iron.
Chen YL; Kong X; Xie Y; Hider RC
J Inorg Biochem; 2018 Mar; 180():194-203. PubMed ID: 29329026
[TBL] [Abstract][Full Text] [Related]
13. Iron chelation-afforded cardioprotection against chronic anthracycline cardiotoxicity: a study of salicylaldehyde isonicotinoyl hydrazone (SIH).
Sterba M; Popelová O; Simůnek T; Mazurová Y; Potácová A; Adamcová M; Guncová I; Kaiserová H; Palicka V; Ponka P; Gersl V
Toxicology; 2007 Jun; 235(3):150-66. PubMed ID: 17459556
[TBL] [Abstract][Full Text] [Related]
14. Chromatographic methods for the separation of biocompatible iron chelators from their synthetic precursors and iron chelates.
Kovaríková P; Mokrý M; Klime J; Vávrová K
J Sep Sci; 2004 Dec; 27(17-18):1503-10. PubMed ID: 15638159
[TBL] [Abstract][Full Text] [Related]
15. Structure-activity relationships of novel salicylaldehyde isonicotinoyl hydrazone (SIH) analogs: iron chelation, anti-oxidant and cytotoxic properties.
Potůčková E; Hrušková K; Bureš J; Kovaříková P; Špirková IA; Pravdíková K; Kolbabová L; Hergeselová T; Hašková P; Jansová H; Macháček M; Jirkovská A; Richardson V; Lane DJ; Kalinowski DS; Richardson DR; Vávrová K; Šimůnek T
PLoS One; 2014; 9(11):e112059. PubMed ID: 25393531
[TBL] [Abstract][Full Text] [Related]
16. 2,6-Dihydroxybenzaldehyde Analogues of the Iron Chelator Salicylaldehyde Isonicotinoyl Hydrazone: Increased Hydrolytic Stability and Cytoprotective Activity against Oxidative Stress.
Jansová H; Kubeš J; Reimerová P; Štěrbová-Kovaříková P; Roh J; Šimůnek T
Chem Res Toxicol; 2018 Nov; 31(11):1151-1163. PubMed ID: 30395451
[TBL] [Abstract][Full Text] [Related]
17. HPLC-DAD and MS/MS analysis of novel drug candidates from the group of aromatic hydrazones revealing the presence of geometric isomers.
Kovaríková P; Vávrová K; Tomalová K; Schöngut M; Hrusková K; Hasková P; Klimes J
J Pharm Biomed Anal; 2008 Sep; 48(2):295-302. PubMed ID: 18222619
[TBL] [Abstract][Full Text] [Related]
18. A study of potential toxic effects after repeated 10-week administration of a new iron chelator--salicylaldehyde isonicotinoyl hydrazone (SIH) to rabbits.
Klimtová I; Simůnek T; Mazurová Y; Kaplanová J; Sterba M; Hrdina R; Gersl V; Adamcová M; Ponka P
Acta Medica (Hradec Kralove); 2003; 46(4):163-70. PubMed ID: 14965167
[TBL] [Abstract][Full Text] [Related]
19. Methyl and ethyl ketone analogs of salicylaldehyde isonicotinoyl hydrazone: novel iron chelators with selective antiproliferative action.
Macková E; Hrušková K; Bendová P; Vávrová A; Jansová H; Hašková P; Kovaříková P; Vávrová K; Simůnek T
Chem Biol Interact; 2012 May; 197(2-3):69-79. PubMed ID: 22521999
[TBL] [Abstract][Full Text] [Related]
20. Examination of diverse iron-chelating agents for the protection of differentiated PC12 cells against oxidative injury induced by 6-hydroxydopamine and dopamine.
Hašková P; Applová L; Jansová H; Homola P; Franz KJ; Vávrová K; Roh J; Šimůnek T
Sci Rep; 2022 Jun; 12(1):9765. PubMed ID: 35697900
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
